Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chester A Mathis

Showing results (61-70 of 203) with videos related to

Pageof 21
Sort By:
Synapse (New York, N.Y.)|December 8, 2017
An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxineW Gordon Frankle, Brigitte Robertson, Gary Maier, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 9, 2019
Association Between Amyloid-β, Small-vessel Disease, and Neurodegeneration Biomarker Positivity, and Progression to Mild Cognitive Impairment in Cognitively Normal IndividualsNeelesh K Nadkarni, Dana Tudorascu, Elizabeth Campbell, et al.
JAMA Neurology|November 15, 2016
Association of Brain Amyloid-β With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E ε4 GenotypeNeelesh K Nadkarni, Subashan Perera, Beth E Snitz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 30, 2012
Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound BBenjamin L Handen, Ann D Cohen, Umapathy Channamalappa, et al.
Neuroimaging Clinics of North America|March 18, 2004
Imaging the pathology of Alzheimer's disease: amyloid-imaging with positron emission tomographyWilliam E Klunk, Henry Engler, Agneta Nordberg, et al.
Archives of Suicide Research : Official Journal of the International Academy for Suicide Research|December 28, 2017
Quantification of 5-HT<sub>1A</sub> and 5-HT<sub>2A</sub> receptor Binding in Depressed Suicide Attempters and Non-AttemptersJ John Mann, Allison V Metts, R Todd Ogden, et al.
Journal of Neurovirology|September 13, 2006
Positron emission tomography imaging of peripheral benzodiazepine receptor binding in human immunodeficiency virus-infected subjects with and without cognitive impairmentClayton A Wiley, Brian J Lopresti, James T Becker, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 2003
Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic miceBrian J Bacskai, Gregory A Hickey, Jesse Skoch, et al.
Molecular Imaging and Biology|March 3, 2011
Human biodistribution and dosimetry of the PET radioligand [¹¹C]flumazenil (FMZ)Charles M Laymon, Rajesh Narendran, Neale S Mason, et al.
Synapse (New York, N.Y.)|March 2, 2011
Evaluation of dopamine D₂/₃ specific binding in the cerebellum for the positron emission tomography radiotracer [¹¹C]FLB 457: implications for measuring cortical dopamine releaseRajesh Narendran, N Scott Mason, Chi-Min Chen, et al.
Pageof 21

Showing results (61-70 of 203) with videos related to

Sort By:
Pageof 21
Synapse (New York, N.Y.)|December 8, 2017
An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxineW Gordon Frankle, Brigitte Robertson, Gary Maier, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 9, 2019
Association Between Amyloid-β, Small-vessel Disease, and Neurodegeneration Biomarker Positivity, and Progression to Mild Cognitive Impairment in Cognitively Normal IndividualsNeelesh K Nadkarni, Dana Tudorascu, Elizabeth Campbell, et al.
JAMA Neurology|November 15, 2016
Association of Brain Amyloid-β With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E ε4 GenotypeNeelesh K Nadkarni, Subashan Perera, Beth E Snitz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 30, 2012
Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound BBenjamin L Handen, Ann D Cohen, Umapathy Channamalappa, et al.
Neuroimaging Clinics of North America|March 18, 2004
Imaging the pathology of Alzheimer's disease: amyloid-imaging with positron emission tomographyWilliam E Klunk, Henry Engler, Agneta Nordberg, et al.
Archives of Suicide Research : Official Journal of the International Academy for Suicide Research|December 28, 2017
Quantification of 5-HT<sub>1A</sub> and 5-HT<sub>2A</sub> receptor Binding in Depressed Suicide Attempters and Non-AttemptersJ John Mann, Allison V Metts, R Todd Ogden, et al.
Journal of Neurovirology|September 13, 2006
Positron emission tomography imaging of peripheral benzodiazepine receptor binding in human immunodeficiency virus-infected subjects with and without cognitive impairmentClayton A Wiley, Brian J Lopresti, James T Becker, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 2003
Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic miceBrian J Bacskai, Gregory A Hickey, Jesse Skoch, et al.
Molecular Imaging and Biology|March 3, 2011
Human biodistribution and dosimetry of the PET radioligand [¹¹C]flumazenil (FMZ)Charles M Laymon, Rajesh Narendran, Neale S Mason, et al.
Synapse (New York, N.Y.)|March 2, 2011
Evaluation of dopamine D₂/₃ specific binding in the cerebellum for the positron emission tomography radiotracer [¹¹C]FLB 457: implications for measuring cortical dopamine releaseRajesh Narendran, N Scott Mason, Chi-Min Chen, et al.
Pageof 21